Pharma News, Research & Solutions

The pandemic has forced us to embrace change in all capacities, a change that informs the "new normal". So how do we move forward?

When I was in college, I learned about the Spanish Flu in a class on the history of medicine. I found the pandemic so fascinating that I reached out to my grandmother Cordelia to ask her about it.

The competitive grants program is designed to support the next generation of researchers working on the front lines to advance understanding and awareness of central nervous system (CNS) disorders.

In Episode 7, Lisa Ling speaks with Johnson & Johnson Chief Scientific Officer Paul Stoffels, M.D., about important advances being made in vaccine development.

This new virtual lab will offer 400 high school students from backgrounds historically underrepresented in STEM a first-hand experience in biotechnology and provide the opportunity to learn directly from leading scientists at Biogen and MIT.

In Episode 6, Ling talks with Jane Halton, Chair of the Coalition for Epidemic Preparedness Innovations, about her work to ensure people globally get access to vaccines.

It was a year ago this month that Johnson & Johnson Innovation first unveiled plans to launch a healthcare innovation facility in Washington, D.C., in collaboration with BARDA—also known as the Biomedical Advanced Research and Development Authority

Investing in promising new pharmaceutical platforms like oligonucleotide therapies could reduce the gap between first detection and total eradication in future pandemics.

In Episode 5, host Lisa Ling speaks with nurse Nicole Lincoln MS, RN, FNP-BC, CCNS who’s on the frontlines in the ICU fighting COVID-19 and nursing innovator, Rebecca Love RN, BS, MSN, FIEL, who’s leading the charge to advocate for her profession.